pentobarbital will reduce the level or effect of linagliptin by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Keep track of. Use of different solutions is strongly advised when linagliptin is to be administered having a CYP3A4 inducerpentobarbital will decrease the extent or effect of erlotinib by influencing hepatic/intestinal